Document Classification

Section Type: RESULTS

Text: At wk 24, placebo-corrected changes with dapagliflozin were as follows : TBW, -2. 08 kg [95 % confidence interval (CI) = -2. 84 to -1. 31 ; P < 0. 0001] ; waist circumference, -1. 52 cm (95 % CI = -2. 74 to -0. 31 ; P = 0. 0143) ; FM, -1. 48 kg (95 % CI = -2. 22 to -0. 74 ; P = 0. 0001) ; proportion of patients achieving weight reduction of at least 5 %, +26. 2 % (95 % CI = 15. 5 to 36. 7 ; P < 0. 0001) ; VAT, -258. 4 cm3 (95 % CI = -448. 1 to -68. 6 ; nominal P = 0. 0084) ; SAT, -184. 9 cm3 (95 % CI = -359. 7 to -10. 1 ; nominal P = 0. 0385).